Identification of Domains of the v-crk Oncogene Product Sufficient for Association with Phosphotyrosine-Containing Proteins

REFERENCES

• Anderson, D. D., R. P. Beckmann, E. H. Harms, K. Nakamura, and M. J. Weber. 1981. Biological properties of “partial” transformation mutants of Rous sarcoma virus and characterization of their pp60src kinase. J. Virol. 37:445-458.
   PubMedGoogle Scholar
• Anderson, D., C. A. Koch, L. Grey, C. Ellis, M. F. Moran, and T. Pawson. 1990. Binding of SH2 domains of phospholipase Cγl, GAP, and Src to activated growth factor receptors. Science 250:979-982.
   PubMed Web of Science ®Google Scholar
• Anderson, S. K., and D. J. Fujita. 1987. Morphf mutants of Rous sarcoma virus: nucleotide sequencing analysis suggests that a class of morphf mutants was generated through splicing of a cryptic intron. J. Virol. 61:1893-1900.
   PubMedGoogle Scholar
• Brugge, J. S., and D. Darrow. 1984. Analysis of the catalytic domain of the phosphotransferase activity of two avian sarcoma virus transforming proteins. J. Biol. Chem. 259:4550-4557.
   PubMedGoogle Scholar
• Bryant, D., and J. T. Parsons. 1982. Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J. Virol. 44:683-691.
   PubMedGoogle Scholar
• Courtneidge, S. A. 1985. Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J. 4:1471-1477.
   PubMedGoogle Scholar
• Courtneidge, S. A., and A. E. Smith. 1983. Polyoma virus transforming protein associates with the product of the c-src gene. Nature (London) 303:435-439.
   PubMed Web of Science ®Google Scholar
• Cross, F. R., E. A. Garber, and H. Hanafusa. 1985. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol. Cell. Biol. 5:2789-2795.
   PubMedGoogle Scholar
• Cross, F. R., and H. Hanafusa. 1983. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of p60src are dispensable for transformation. Cell 34:597-607.
   PubMed Web of Science ®Google Scholar
• DeClue, J. E., and G. S. Martin. 1989. Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J. Virol. 63:542-554.
   PubMed Web of Science ®Google Scholar
• DeClue, J. E., I. Sadowski, G. S. Martin, and T. Pawson. 1987. A conserved domain regulates interactions of the v-fps proteintyrosine kinase with the host cell. Proc. Natl. Acad. Sci. USA 84:9064-9068.
   PubMedGoogle Scholar
• Drubin, D. G., J. Mulholland, Z. Zhu, and D. Botstein. 1990. Homology of a yeast actin-binding protein to signal transduction proteins and myosin-I. Nature (London) 343:288-290.
   PubMed Web of Science ®Google Scholar
• Emori, Y., Y. Homma, H. Sorimachi, H. Kawasaki, O. Nakanishi, K. Suzuki, and T. Takenawa. 1989. A second type of rat phosphoinositide-specific phospholipase C containing a src- related sequence not essential for phosphoinositide-hydrolyzing activity. J. Biol. Chem. 264:21885-21890.
   PubMedGoogle Scholar
• Espino, P. C., R. Harvey, R. L. Schweickgardt, G. A. White, A. E. Smith, and S. H. Cheng. 1990. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation. Oncogene 5:283-293.
   PubMedGoogle Scholar
• Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
   PubMed Web of Science ®Google Scholar
• Hamaguchi, M., C. Grandori, and H. Hanafusa. 1988. Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells : analysis by use of anti-phosphotyrosine antibodies. Mol. Cell. Biol. 8:3035-3042.
   PubMedGoogle Scholar
• Hanafusa, H. 1969. Rapid transformation of cells by Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 63:318-325.
   PubMedGoogle Scholar
• Hirai, H., and H. E. Varmus. 1990. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src. Mol. Cell. Biol. 10:1307-1318.
   PubMed Web of Science ®Google Scholar
• Iba, H., T. Takeya, F. R. Cross, T. Hanafusa, and H. Hanafusa. 1984. Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 81:4424-4428.
   PubMedGoogle Scholar
• Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
   PubMed Web of Science ®Google Scholar
• Kato, J., T. Takeya, C. Grandori, H. Iba, J. B. Levy, and H. Hanafusa. 1986. Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein. Mol. Cell. Biol. 6:4155-4160.
   PubMed Web of Science ®Google Scholar
• Kawai, S. 1980. Transformation of rat cells by fusion-infection with Rous sarcoma virus. J. Virol. 34:772-776.
   PubMedGoogle Scholar
• Kimura, G., A. Itagaki, and J. Summers. 1975. Rat cell line 3Y1 and its virogenic polyoma- and SV40-transformed derivatives. Int. J. Cancer 15:694-706.
   PubMedGoogle Scholar
• Kitamura, N., and M. Yoshida. 1983. Small deletion in src of Rous sarcoma virus modifying transformation phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity. J. Virol. 46:985-992.
   PubMedGoogle Scholar
• Kornbluth, S., M. Sudol, and H. Hanafusa. 1987. Association of the polyomavirus middle-T antigen with c-yes protein. Nature (London) 325:171-173.
   PubMed Web of Science ®Google Scholar
• Lau, A. F. 1986. Phosphotyrosine-containing 120,000-dalton protein co-immunoprecipitated with pp6v-src from Rous sarcoma virus-transformed mammalian cells. Virology 151:86-99.
   PubMedGoogle Scholar
• Lau, A. F. 1989. Evidence that a phosphotyrosine-containing 120,000 dalton protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src. Oncogene Res. 1:185-194.
   Google Scholar
• Lehmann, J. M., G. Riethmuller, and J. P. Johnson. 1990. Nck, a melanoma cDNA encoding a cytoplasmic protein consisting of the src homology units SH2 and SH3. Nucleic Acids Res. 18:1048.
   PubMed Web of Science ®Google Scholar
• Leto, T. L., K. J. Lomax, B. D. Volpp, H. Nunoi, J. M. G. Sechler, W. M. Nauseef, R. A. Clark, J. I. Gallin, and H. L. Malech. 1990. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 248:727-730.
   PubMed Web of Science ®Google Scholar
• Lipsich, L. A., A. J. Lewis, and J. S. Brugge. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol. 48:352-360.
   PubMedGoogle Scholar
• Lomax, K. J., T. L. Leto, H. Nunoi, J. I. Gallin, and H. L. Malech. 1989. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245:409-412.
   PubMedGoogle Scholar
• Marshall, C. P., and H. Hanafusa. Unpublished data.
   Google Scholar
• Marshall, M. S., W. S. Hill, A. S. Ng, U. S. Vogel, M. D. Schaber, E. M. Scolnick, R. A. F. Dixon, I. S. Sigal, and J. B. Gibbs. 1989. A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity. EMBO J. 8:1105-1110.
   PubMedGoogle Scholar
• Matsuda, M., C. P. Marshall, and H. Hanafusa. 1990. Purification of crk oncogene product, P47gag-crk, from insect cells. J. Biol. Chem. 265:12000-12004.
   PubMedGoogle Scholar
• Matsuda, M., B. J. Mayer, Y. Fukui, and H. Hanafusa. 1990. Binding of oncoprotein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537-1539.
   PubMedGoogle Scholar
• Matsuda, M. et al. Unpublished data.
   Google Scholar
• Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1988. A novel viral oncogene with structural similarity to phospholipase C. Nature (London) 332:272-275.
   PubMed Web of Science ®Google Scholar
• Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1989. Characterization of P47gag-crk, a novel oncogene product with sequence similarity to a putative modulatory domain of protein-tyrosine kinases and phospholipase C. Cold Spring Harbor Symp. Quant. Biol. 53:907-914.
   Google Scholar
• Mayer, B. J., and H. Hanafusa. 1990. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains, and correlation between increased cellular phosphotyrosine and transformation. J. Virol. 64:3581-3589.
   PubMedGoogle Scholar
• Mayer, B. J., and H. Hanafusa. 1990. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity. Proc. Natl. Acad. Sci. USA 87:2638-2642.
   PubMed Web of Science ®Google Scholar
• Mayer, B. J., and H. Hanafusa. Unpublished data.
   Google Scholar
• Moran, M. F., C. A. Koch, D. Anderson, C. Ellis, L. England, G. S. Martin, and T. Pawson. 1990. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87:8622-8626.
   PubMed Web of Science ®Google Scholar
• Neckameyer, W. S., and L.-H. Wang. 1984. Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses. J. Virol. 50:914-921.
   PubMed Web of Science ®Google Scholar
• O’Brien, M. C., Y. Fukui, and H. Hanafusa. 1990. Activation of proto-oncogene p60c-src by point mutations in the SH2 domain. Mol. Cell. Biol. 10:2855-2862.
   PubMedGoogle Scholar
• Pawson, T. 1988. Non-catalytic domains of cytoplasmic proteintyrosine kinases: regulatory elements in signal transduction. Oncogene Res. 3:491-495.
   Google Scholar
• Potts, W. M., M. Olsen, D. Boettiger, and V. M. Vogt. 1987. Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukemia viruses. J. Gen. Virol. 68:3177-3182.
   PubMedGoogle Scholar
• Potts, W. M., A. B. Reynolds, T. J. Lansing, and J. T. Parsons. 1988. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res. 3:343-355.
   PubMedGoogle Scholar
• Raymond, V. W., and J. T. Parsons. 1987. Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology 160:400-410.
   PubMedGoogle Scholar
• Reichman, C. T., and H. Hanafusa. Submitted for publication.
   Google Scholar
• Reynolds, A. B., S. B. Kanner, H.-C. R. Wang, and J. T. Parsons. 1989. Stable association of activated pp60src with two tyrosine phosphorylated cellular proteins. Mol. Cell. Biol. 9:3951-3958.
   PubMed Web of Science ®Google Scholar
• Rodaway, A. R. F., M. J. E. Sternberg, and D. L. Bentley. 1989. Similarity in membrane proteins. Nature (London) 342:624.
   PubMed Web of Science ®Google Scholar
• Rosenberg, A. H., B. N. Lade, D.-S. Chui, S.-W. Lin, J. J. Dunn, and F. W. Studier. 1987. Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56:125-135.
   PubMed Web of Science ®Google Scholar
• Sadowski, L., and T. Pawson. 1987. Catalytic and non-catalytic domains of the Fujinami sarcoma virus P130gag-fps proteintyrosine kinase distinguished by the expression of v-fps polypeptides in Escherichia coli. Oncogene 1:181-191.
   PubMedGoogle Scholar
• Sadowski, I., J. C. Stone, and T. Pawson. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol. Cell. Biol. 6:4396-4408.
   PubMed Web of Science ®Google Scholar
• Stahl, M. L., C. R. Ferenz, K. L. Kelleher, R. W. Kriz, and J. L. Knopf. 1988. Sequence similarity of phospholipase C with the non-catalytic region of src. Nature (London) 332:269-272.
   PubMed Web of Science ®Google Scholar
• Suh, P.-G., S. H. Ryu, K. H. Moon, H. W. Suh, and S. G. Rhee. 1988. Inositol phospholipid-specific phospholipase C: complete cDNA and protein sequences and sequence homology to tyrosine kinase-related oncogene products. Proc. Natl. Acad. Sci. USA 85:5419-5423.
   PubMed Web of Science ®Google Scholar
• Tachibana, H., Y. Inoue, T. Kanehisa, and Y. Fukami. 1988. Local similarity in the amino acid sequence between the noncatalytic region of Rous sarcoma virus oncogene product p60v-src and intermediate filament proteins. J. Biochem. 104:869-872.
   PubMedGoogle Scholar
• Trahey, M., G. Wong, R. Halenbeck, B. Rubinfeld, G. A. Martin, M. Landner, C. M. Long, W. J. Crosier, K. Watt, K. Koths, and F. McCormick. 1988. Molecular cloning of two types of GAP complementary DNA from human placenta. Science 242:1697-1700.
   PubMed Web of Science ®Google Scholar
• Trueheart, J., J. D. Boeke, and G. R. Fink. 1987. Two genes required for cell fusion during yeast conjugation: evidence for a pheromone-induced surface protein. Mol. Cell. Biol. 7:2316-2328.
   PubMedGoogle Scholar
• Vogel, U. S., R. A. F. Dixon, M. D. Schaber, R. E. Diehl, M. S. Marshall, E. M. Scolnick, I. S. Sigal, and J. B. Gibbs. 1988. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature (London) 335:90-93.
   PubMed Web of Science ®Google Scholar
• Volpp, B. D., W. M. Nauseef, J. E. Donelson, D. R. Moser, and R. A. Clark. 1989. Cloning of the cDNA and functional expression the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc. Natl. Acad. Sci. USA 86:7195-7199.
   PubMedGoogle Scholar
• Wang, H.-C. R., and J. T. Parsons. 1989. Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability. J. Virol. 63:291-302.
   PubMedGoogle Scholar
• Wasenius, V.-M., M. Saraste, P. Salven, M. Eramaa, L. Holm, and V.-P. Lehto. 1989. Primary structure of the brain α-spectrin. J. Cell Biol. 108:79-93.
   PubMedGoogle Scholar
• Wendler, P. A., and F. Boschelli. 1989. Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa. Oncogene 4:231-236.
   PubMedGoogle Scholar